Willow Biosciences Inc (TO:WLLW) — Market Cap & Net Worth
Market Cap & Net Worth: Willow Biosciences Inc (WLLW)
Willow Biosciences Inc (TO:WLLW) has a market capitalization of $5.15 Million (CA$7.12 Million) as of September 17, 2026. Listed on the TO stock exchange, this Canada-based company holds position #28607 globally and #1272 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Willow Biosciences Inc's stock price CA$0.17 by its total outstanding shares 147196992 (147.20 Million). Also see WLLW total asset value for a full breakdown of the balance sheet.
Willow Biosciences Inc Market Cap History: 2018 to 2025
Willow Biosciences Inc's market capitalization history from 2018 to 2025. Data shows growth from $4.79 Million to $18.10 Million (18.24% CAGR). Also see WLLW cash flow conversion for how efficiently the company converts equity into cash flow.
Willow Biosciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Willow Biosciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Willow Biosciences Inc share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.48x
Willow Biosciences Inc's market cap is 1.48 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $4.79 Million | $16.91K | -$1.64 Million | 283.31x | N/A |
| 2019 | $68.15 Million | $4.58K | -$44.57 Million | 14866.32x | N/A |
| 2020 | $124.58 Million | $10.00K | -$33.99 Million | 12458.17x | N/A |
| 2021 | $47.92 Million | $133.00K | -$6.17 Million | 360.27x | N/A |
| 2022 | $12.25 Million | $821.00K | -$14.81 Million | 14.91x | N/A |
| 2023 | $10.65 Million | $1.17 Million | -$13.03 Million | 9.09x | N/A |
| 2024 | $6.92 Million | $4.66 Million | -$6.19 Million | 1.48x | N/A |
Competitor Companies of WLLW by Market Capitalization
Companies near Willow Biosciences Inc in the global market cap rankings as of September 17, 2026. Review WLLW goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Willow Biosciences Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Willow Biosciences Inc Historical Marketcap From 2018 to 2025
Between 2018 and today, Willow Biosciences Inc's market cap moved from $4.79 Million to $ 18.10 Million, with a yearly change of 18.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | CA$18.10 Million | +161.54% |
| 2024 | CA$6.92 Million | -35.00% |
| 2023 | CA$10.65 Million | -13.04% |
| 2022 | CA$12.25 Million | -74.44% |
| 2021 | CA$47.92 Million | -61.54% |
| 2020 | CA$124.58 Million | +82.81% |
| 2019 | CA$68.15 Million | +1322.22% |
| 2018 | CA$4.79 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 21st, 2026 the market cap of Willow Biosciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.15 Million USD |
| MoneyControl | $5.15 Million USD |
| MarketWatch | $5.15 Million USD |
| marketcap.company | $5.15 Million USD |
| Reuters | $5.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Willow Biosciences Inc
Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. Willow Biosciences Inc. was founded in 20… Read more